-
Denmark, Australia in the spotlight in Eurovision second semi
-
Heavy Russian strikes on Kyiv kill one, wound 31
-
Xi warns Trump on Taiwan at Beijing summit
-
Iran war and oil dominate BRICS meet in India
-
Bone appetit: Paris pups lap up treats at dog-centric spots
-
Kohli senses end after roaring back to form with IPL century
-
India bars sugar exports until September
-
Madonna, Shakira, BTS to headline first World Cup final half-time show
-
Japan takes 'half step' toward fixing slow retrial system
-
Honda posts operating loss, first since 1957
-
Madonna, Shakira, BTS to headline World Cup final half-time show
-
A quarter of World Cup games risk searing heat: scientists
-
Six hantavirus cruise passengers head to Australia
-
Suspect detained in Philippine senate gunfire: police
-
Cavs top Pistons in overtime for 3-2 series lead
-
Canadian football ready for World Cup coming out party
-
US court suspends sanctions on UN expert on Palestinians
-
Asia markets mixed as Trump-Xi summit, AI trade dominate
-
'Promised to us': The Israelis dreaming of settling south Lebanon
-
'Rare, meaningful': North Korean football team ventures into South
-
In-form Messi hits brace as Miami win 5-3 at Cincinnati in MLS
-
Historic Swiss solar-powered plane crashes into sea
-
A woman UN leader is 'historical justice,' says Ecuadoran contender for top job
-
Indian pharma fuels Africa's 'zombie drug' and opioid crisis
-
After months of blackout, Iran gives internet to select few
-
Wood urges New Zealand to 'create some history' at World Cup
-
In Washington, the fight to preserve Black cemeteries
-
US children's book author sentenced to life after poisoning husband
-
Emotional Vin Diesel leads 'Fast and Furious' tribute in Cannes
-
Battery X Metals Achieves Milestone with Delivery of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Machine Featuring Design Enhancements, Advancing Strategic Commercialization Initiatives
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 14
-
Akkodis Recognized in HFS Horizons 2026 Report for Enterprise Ready Agentic AI Services
-
Lexus Of Oakville Recognized for Redefining the Luxury Dealership Experience With 2026 Consumer Choice Award
-
US renews offer of $100 mn to Cuba if it cooperates
-
City still 'alive' but need Arsenal slip: Guardiola
-
Man City ease past Palace to keep pressure on Arsenal
-
Alaves end champions Barca's bid for 100-point record
-
US jury begins deliberations on 737 MAX victim suit against Boeing
-
PSG clinch fifth straight Ligue 1 title
-
Inter Milan win Italian Cup to secure domestic double
-
Man City see off Palace to keep pressure on Arsenal
-
Trump and Xi set for high-stakes talks in Beijing
-
S&P 500, Nasdaq end at records as oil prices retreat
-
Iran holds World Cup send-off for national football team
-
McIlroy's toe 'totally fine' after nine-hole PGA practice
-
Rare 'Ocean Dream' blue-green diamond sells for $17 mn at auction
-
California says probing possible violations over World Cup ticket sales
-
US races to secure rare earths to rebuild depleted arsenal
-
Matthew Perry drug middleman jailed for two years
-
Warsh confirmed as Fed chair as central bank faces Trump assault
Australia doctors warn of 'excessive' medical weed prescriptions
Australia's medical cannabis industry is "excessively" prescribing weed with little oversight and needs urgent regulation, the country's top doctors association and pharmacists warned on Tuesday.
Legalised for medical use in 2016, Australians are estimated to have spent up to $500 million on licit pot last year, according to a think tank.
But on Tuesday the Australian Medical Association (AMA) and the Pharmacy Guild of Australia said the industry was too often issuing prescriptions without "proper clinical oversight".
"Urgent action is needed to ensure medicinal cannabis is prescribed, dispensed and regulated in the same manner as other registered drugs of dependence," AMA President Danielle McMullen said.
While acknowledging evidence suggesting medical cannabis can help treat epilepsy, chemotherapy-induced nausea or Multiple Sclerosis, doctors warned the system was being "exploited".
"There is little, or no evidence base for many of the conditions for which it is being prescribed, such as anxiety, insomnia or depression," McMullen said.
In their submission to an Australian government inquiry into the industry, the AMA called for "comprehensive reform" of the way medical cannabis was bought and sold.
Members working in emergency departments were calling for more resources to deal with growing numbers of patients with cases related to excessive intake of cannabis, including psychosis, they said.
"Alarmingly, doctors are seeing medicinal cannabis use in people who have pre-existing psychotic conditions," they warned.
The AMA warned telehealth models -- in which patients can be issued prescriptions online without an in-person doctor visit -- were being "exploited as commercial pathways for unapproved products".
This year, newspaper the Age revealed that one doctor working for medical cannabis giant Montu had issued 72,000 prescriptions to 10,000 patients in just two years.
In some instances, the newspaper reported, consultations with patients were scheduled to last no longer than 10 minutes.
The global medical cannabis market is expected to grow to over $65 billion by 2030, according to consulting firm Grand View Research.
E.Hall--AT